Order win▲ Bullish for Lupin

Lupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL

1 source · first seen 09:50 28 Sept · updated 09:50 28 Sept

The brief

Written from 1 report · check the source before you trade

Lupin received USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mL
It offers an alternative administration option for adults requiring anticoagulation therapy
Tentative US approval may support Lupin’s product pipeline and future sales

Pick a tag to see all its stories

1 report · earliest 09:50